10 minute read

APRIL 23, 2025

We can’t believe the AIRA 2025 National Meeting is already next week! We are so excited and wanted to remind all of you to… 

Register Now for Pre-conference Workshops on April 28

Registration is open for two exciting pre-conference workshops on Monday, April 28, from 9 a.m. to 12:30 p.m. These interactive sessions will help you dive into critical topics before the National Meeting kicks off in the afternoon.

Programmatic Workshop: Project Management Essentials: Leveraging AI for Efficiency

Learn how to integrate AI into project management practices to streamline workflows, enhance collaboration, and improve resource allocation. This workshop provides foundational project management skills with a focus on AI applications for task automation, risk management, and decision making.

Technical Workshop: Building Blocks for HTI-2 Readiness

Dive into the latest proposed rule from ASTP/ONC affecting the IIS and immunization community. Work directly with AIRA technical and policy leaders to work through hands-on exercises that will shed light on how HL7 ACK messages, error handling (ERR-5), and IIS policies impact immunization data exchange. It’s a valuable session for both technical and non-technical participants!

The price to register for either workshop is $450.

Check out the #AIRA2025 Keynote Speaker

We’re thrilled that Scott Crabtree, Founder and Chief Happiness Officer at Happy Brain Science, will be our keynote speaker at the AIRA 2025 National Meeting. A leader in neuroscience and psychology, Scott empowers individuals and organizations to apply cutting-edge science to boost happiness.

Register now and join us for an unforgettable session.

Sign up for your 30-minute AART clinic and talk data with our experienced AIRA staff!

Don’t miss your chance to meet one on one with AIRA technical staff during an AART clinic session, running April 29–May 1. Whether you’re looking to dive into your latest Measurement and Improvement (M&I) results or get expert feedback on your progress, these sessions are your time to focus, ask questions, and move forward with clarity.

Spots are limited—book your appointment now or scan the QR code below!

Join us on Monday, May 19, 2025, from 4 to 5 p.m. ET as we spotlight highly rated breakout sessions from the AIRA 2025 National Meeting in Spokane, Washington!

Whether you're attending the meeting in person or unable to make the trip this year, this session is a great way to stay connected and catch up on key insights and updates shared during the event.

Once registered, you will receive a confirmation email with calendar links for easy access. If you can’t make it, a recording will be available in the AIRA Repository. We hope you’ll join us on May 19!

The IIS Data Analyst Collaborative (IDAC) is a discussion-based offering where participants explore topics relevant to IIS data. Held quarterly on the third Thursday of the month from 1 to 2 p.m. ET, each session offers a space for conversation and peer learning. Participation is limited to encourage meaningful dialogue and to give both new and experienced analysts the chance to ask questions and share insights with the community.

Since February 2024, five IDAC sessions have been held. Topics, takeaway notes, and recordings from past sessions are listed below.

The next IDAC session will take place on May 15, 2025, from 1 to 2 p.m. ET. The discussion will focus on data cleansing, including improving demographics, fragmented records, issues with merging records, and the best ways to address “moved or gone elsewhere” (MOGE). To register for the event, follow the link here. 

IDAC Session Resources:

• February 2024: IISAR Annual Report Measures
• April 2024: Coverage Rate Assessment
• June 2024: Denominator Inflation
• November 2024: Real vs. Artificial Coverage Rates, Session Recording
• February 2025: Non-VFC Provider Population, Session Recording

Session takeaways and recordings are also posted to the IIS Data Analyst Forum (IDAF). IDAF is an online forum where people who work with IIS data can talk, access additional resources, check out publications, and post and answer questions.

Join IDAF by scanning the below QR code:

AIRA members can submit and review information requests—a circulation of questions to and answers from the community. To submit an information request to the IIS community, email Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser. with “Information Request” in the subject line. Anyone who provides a meaningful response to an information request will be entered into a raffle to win a $25 gift card and will be recognized during the AIRA 2025 National Meeting awards ceremony. 

Open Information Request

• The Nevada Department of Health and Human Services is seeking information regarding Medicaid ID. Is your IIS storing Medicaid ID? If so:

• How is this information updated and maintained?
• How is this information used? For example, is it used to support patient matching for HEDIS extracts?
• Do you have lessons learned to share regarding storage and use of Medicaid ID?

If you are willing to share any relevant information, please respond to David Crowell at Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser. and copy Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser. by today, April 23. Don’t forget to include your contact information for follow-up.

Information requests are viewable only by individual members and individuals affiliated with member and partner organizations. Recent information requests can be found by using the “Information Requests” filter in the AIRA Repository. Just log in to view these valuable resources! If you have any questions, please email Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser..

BACK TO TOP

Background

The Advisory Committee on Immunization Practices (ACIP) met on April 15–16 to discuss the following vaccines: mpox, Lyme disease, influenza, COVID-19, pneumococcal, human papillomavirus (HPV), cytomegalovirus (CMV), meningococcal, respiratory syncytial virus (RSV) – adults and maternal/pediatric, and chikungunya.

Summary of Votes

Below is a summary of the votes that took place.

Meningococcal vaccines

• ACIP recommends GSK’s MenABCWY vaccine (Penmenvy®) may be used when both MenACWY and MenB are indicated at the same visit. This applies to:
  • Healthy persons aged 16–23 years (routine schedule) when shared clinical decision making favors administration of MenB vaccine
  • Persons aged ≥10 years who are at increased risk for meningococcal disease (e.g., because of persistent complement deficiencies, complement inhibitor use, or functional or anatomic asplenia)
• A Vaccines for Children (VFC) program resolution to incorporate a new combination pentavalent vaccine to prevent meningococcal disease was passed.

RSV adult

• ACIP recommends adults 50–59 years of age who are at increased risk of severe RSV disease receive a single dose of RSV vaccine.
  • CDC will publish “Clinical Considerations” that describe chronic medical conditions and other risk factors for severe RSV disease for use in this risk-based recommendation.
  • The risk factors for 50- to 59-year-olds will be the same as the current risk factors for 60- to 74-year-olds.
  • At this time, RSV vaccination is recommended as a single dose only. A further RSV vaccination is NOT recommended for persons who have already received another dose.
  • RSV vaccine can be administered with any product licensed in this age group.

Chikungunya vaccines

Three votes for chikungunya vaccines took place.

• Vote 1:
  • ACIP recommends virus-like particle chikungunya vaccine for persons aged ≥12 years traveling to a country or territory where there is a chikungunya outbreak.
  • In addition, virus-like particle chikungunya vaccine may be considered for persons aged ≥12 years traveling or taking up residence in a country or territory without an outbreak but with elevated risk for U.S. travelers planning travel for an extended period of time—e.g., six months or more.
• Vote 2:
  • ACIP recommends virus-like particle chikungunya vaccine for laboratory workers with potential for exposure to chikungunya virus.
  • This is consistent with language of recommendation for vaccination of laboratory workers with live attenuated chikungunya vaccine approved by ACIP in February 2024.
• Vote 3:
  • ACIP recommends live attenuated chikungunya vaccine for persons aged ≥18 years traveling to a country or territory where there is a chikungunya outbreak.
  • In addition, live attenuated chikungunya vaccine may be considered for persons aged ≥18 years traveling or taking up residence in a country or territory without an outbreak but with elevated risk for U.S. travelers planning travel for an extended period of time—e.g., six months or more.
  • An age of ≥65 years is a precaution for use of CHIK-LA.

Impact on IIS

Clinical decision support for immunization (CDSi) rules are regularly developed and reviewed. Updates are typically available shortly after the ACIP recommendations become official and sufficient online material has been published.

Presentation slides are available on the ACIP website. The next scheduled ACIP meeting will be held June 25–26.

For a more detailed summary, view the April 23 issue of IZ Express.

AIRA’s Standard and Analytics Team is happy to announce the latest releases of these documents to aid jurisdictions and health technology partners with AART. 

1. AART End User Update: provides details of software changes or updates made from November 2023 through January 2025 to enhance and improve the end user experience. Recommended readers include IIS managers, immunization program or IIS staff, and health technology partners. 
2. AART Settings and User Management: provides detailed instruction for AART administrators regarding their responsibility for maintaining the measurement and sharing settings and AART user management (new and existing users). Recommended readers include IIS managers, immunization program or IIS staff, and health technology partners that are AART administrators for their organization. 

For more information and to access these documents, please visit AIRA’s Aggregate Analysis Reporting Tool page. 

AIRA’s Standards and Analytics Team is excited to share the release of an updated instructional video on AART, designed to aid jurisdictions and health technology partners by: 

• Providing an overview of the information and reports provided via AART 
• Educating on how to engage with the IIS community or peers 
• Referring users to resources available to them
• Recommending AIRA’s Technical Assistance Team to assist with technical assistance needs 

Recommended viewers include new or existing IIS, immunization programs, or health technology partner staff. For more information, please visit AIRA’s Aggregate Analysis Reporting Tool page.  

BACK TO TOP

BACK TO TOP

American Immunization Registry Association
1717 Pennsylvania Avenue NW
Suite 1025 
Washington, DC 20006

© Copyright 2023, American Immunization Registry Association